La Jolla, CA, United States of America

Danielle K Neff

This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2007-2015.

USPTO Granted Patents = 6 

% Patents Active = 50.0



Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • San Diego, CA (US) (2007)
  • La Jolla, CA (US) (2012 - 2015)

Company Filing History:


Years Active: 2007-2015

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Danielle K Neff

Introduction

Danielle K Neff is a prominent inventor based in La Jolla, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate histamine receptors. With a total of 6 patents to her name, her work has the potential to impact various medical conditions.

Latest Patents

Among her latest patents, Danielle has developed thieno- and furo-pyrimidine compounds that serve as histamine H4 receptor modulators. These compounds are valuable in pharmaceutical compositions and methods aimed at modulating histamine H4 receptor activity. They hold promise for treating disease states, disorders, and conditions mediated by H4 receptor activity, such as inflammation.

Career Highlights

Danielle K Neff is currently associated with Janssen Pharmaceutica NV, where she continues to innovate and contribute to the pharmaceutical industry. Her expertise in receptor modulation has positioned her as a key player in her field.

Collaborations

Throughout her career, Danielle has collaborated with notable colleagues, including James Patrick Edwards and Deborah M Smith. These partnerships have further enhanced her research and development efforts.

Conclusion

Danielle K Neff's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her contributions to histamine receptor modulation are paving the way for new treatments and therapies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…